This paper discusses the effectiveness of two animal composters in containing diseases caused by spore-forming bacteria.
Scientists will conduct research in two national parks in southern Africa that differ in the timing and severity of anthrax outbreaks. They will investigate the roles of host, pathogen and environment to understand how the pathogen-host interaction evolves and contributes to the differences in anthrax occurrences in the two study areas.
This article describes Bacillus anthracis strains isolated during an outbreak of anthrax on the Yamal Peninsula in the summer of 2016 and independently in Yakutia in 2015.
One mystery about anthrax is why outbreaks are so different across the planet. In some areas outbreaks occur annually with few cases, while in other areas explosive outbreaks occur with decades or longer in between.
Researchers describe deoxy glycosides responsible for specific carbohydrate-phospholipid interactions, causing phosphatidylethanolamine lamellar-to-inverted hexagonal phase transition and acting over B. anthracis and Bacillus cereus as potent and selective bactericides.
Researchers have developed an innovative strategy for preventing the anthrax bacterium from absorbing iron, which is crucial for its survival.
Two doses of the vaccine provided complete protection against both inhalational anthrax and pneumonic plague in animal models. Further, results establish the T4 nanoparticle as a novel platform to develop multivalent vaccines against pathogens of high public health significance.
Ukraine’s Health Ministry has said that over 13,500 places in the country have potential danger over the possible spread of anthrax, and these are mainly former burial grounds for cattle in rural areas.
According to the Minister of Forestry and Agriculture, two neighborhoods of Istanbul’s Silivri district were quarantined and more than 3000 animals were vaccinated as a precaution.
Anthrax has been detected in 23 locations with 54 animals killed, mainly bovines.